DiscoverThe JM BuzzHow Drug Price Regulations Backfired in India
How Drug Price Regulations Backfired in India

How Drug Price Regulations Backfired in India

Update: 2024-07-18
Share

Description

A Journal of Marketing study shows how India aimed to make essential medicines more affordable but inadvertently ended up reducing drug sales.




Read an in-depth recap of this research here: https://www.ama.org/2024/06/04/how-an-indian-government-policy-backfired-prescription-drug-price-regulations-led-to-more-marketing-for-unregulated-medications/




Read the full Journal of Marketing article here: https://doi.org/10.1177/00222429241242685




Reference: Saravana Jaikumar, Pradeep K. Chintagunta, and Arvind Sahay, “Do No Harm? Unintended Consequences of Pharmaceutical Price Regulation in India,” Journal of Marketing.




Narrator: Adalgisa Butkewitsch


Acknowledgments: Sushma Kambagowni


Topics: prescription drugs, healthcare, India, drug prices, regulations




The JM Buzz Podcast is a production of the American Marketing Association's Journal of Marketing and is produced by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠University FM

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

How Drug Price Regulations Backfired in India

How Drug Price Regulations Backfired in India

Journal of Marketing